Guerbet

58 articles about Guerbet

• Guerbet : 2016 Annual Results

  3/29/2017

• Guerbet: 2016 Revenue

  2/15/2017

• Guerbet Expands Distribution Partnership In Canada With Methapharm

  2/1/2017

• Guerbet Grabs FDA Nod for the OptiOne Single-Head Contrast Delivery System

  2/11/2016

• Mallinckrodt Completes Sale Of Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million

  11/30/2015

• Frost & Sullivan Applauds Guerbet's Novel, Syringe-free CT Contrast Injector, FlowSens

  10/26/2015

• Mallinckrodt Divests Contrast Media Biz to Guerbet For $270 Million

  7/28/2015

• Guerbet: 2014 Annual Results

  3/12/2015

• Guerbet 2014 Annual Revenue: EU411.6M (+ 5.6%) At Constant Exchange Rates

  2/11/2015

• Guerbet To Exhibit Recently U.S. Approved Imaging Agents At 100 Year Anniversary Of RSNA

  11/13/2014

• Guerbet: 2014 First-Half Results

  7/30/2014

• Guerbet Release: FDA Approves Lipiodol® (Ethiodized Oil) Injection For Imaging Of Tumors In Adults With Known Hepatocellular Carcinoma (HCC)

  4/11/2014

• Guerbet Receives FDA Approval For A New Manufacturing Plant For Lipiodol® (Ethiodized Oil) Injection

  2/20/2014

• Guerbet Release: FDA Grants Orphan Drug Designation to Lipiodol&#0174 (Ethiodized Oil) Injection for Management of Patients with Known Hepatocellular Carcinoma (HCC)

  10/21/2013

• Guerbet Release: First Injection of Dotarem&#0174 (Gadoterate Meglumine) in US Performed at Cincinnati Children's Hospital Medical Center

  7/26/2013

• FDA Approves Guerbet's New Gadolinium-Based MRI Agent

  3/21/2013

• Medical Imaging Drugs Advisory Committee Recommends Approval of Guerbet NDA for Dotarem&#0174 (gadoterate meglumine)

  2/15/2013

• Guerbet - Another Proof That There Is No Difference Between Low-Osmolarity Contrast Agents And Iso-Osmolar Agent For Prevention Of Contrast-Induced Nephropathy

  10/27/2006